Canonical ingredient
Erythromycin
ERYTHROMYCIN
41 linked products
Official identifiers
Names and synonyms
- Erythromycin (en)
- Érythromycine (fr)
- Érythromycine (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Equivalent concepts in other registries
These links require an exact shared identifier; names alone are never sufficient.
- erythromycin A
GLOBAL · CAS 114-07-8
Verification source
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
ALTI-ERYTHROMYCIN TAB 250MG USP
250 · MG · TAB
BENZAMYCIN
3 · % · W/W
EMYCIN ECT 250MG
250 · MG · TAB
ERYBID
500 · MG
ERYC DELAYED-RELEASE CAPSULES
250 · MG
ERYC DELAYED-RELEASE CAPSULES
333 · MG
ERYMYCIN OPHTHALMIC OINTMENT 5MG/G
5 · MG · G
ERYSOL
2 · %
ERYTHRO 200
200 · MG · ML
ERYTHRO 36
50 · MG · ML
ERYTHRO-200 (STERILE INJECTION)
200 · MG · ML
ERYTHRO-36 - LIQ IMM 50MG/ML
50 · MG · ML
ERYTHRO-BASE
250 · MG
ERYTHRO-BASE TAB 250MG USP
250 · MG
ERYTHRO-DRY COW - LIQ IMM 50MG/ML
50 · MG · ML
ERYTHRO-EC
250 · MG
ERYTHRO-EC
333 · MG
ERYTHROMID TAB 250MG
250 · MG
ERYTHROMYCIN
5 · MG · G
ERYTHROMYCIN CAPSULES USP 250MG
250 · MG · CAP
ERYTHROMYCIN OPHTHALMIC OINTMENT U.S.P.
5 · MG · G
ERYTHROMYCIN OPHTHALMIC OINTMENT USP
5 · MG · G
EURO-ERYTHROMYCIN OPHTHALMIC OINTMENT USP
5 · MG · G
GALLIMYCIN 100 INJ 100MG/ML
100 · MG · ML
GALLIMYCIN 200 INJ
200 · MG · ML
GALLIMYCIN 36 INJ 50MG/ML
50 · MG · ML
GALLIMYCIN-200 (USP STERILE ERYTHROMYCIN INJECTION)
200 · MG · ML
GALLIMYCIN-36
50 · MG · ML
ILOTYCIN CRYST OP ONT 0.5% 52
.5 · % · %
NOVO-RYTHRO ENCAP 250MG
250 · MG · CAP
ODAN-ERYTHROMYCIN
5 · MG · G
PCE
333 · MG
PDP-ERYTHROMYCIN
5 · MG · G
PMS-ERYTHROMYCIN
5 · MG · G
SANS-ACNE SOLUTION
2 · % · %
STATICIN LOT
1.5 · % · %
STIEVAMYCIN FORTE
4 · %
STIEVAMYCIN MILD
4 · %
STIEVAMYCIN REGULAR
4 · %
T-STAT LOT
2 · % · %
T-STAT PAD-LOT
2 · % · %